Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104


Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.

Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyrière H, Basset N, Autran D, Roche C, Kalamarides M, Roche PH, Fuentes S, Tabouret E, Barrie M, Cohen A, Honoré S, Boucekine M, Baumstarck K, Figarella-Branger D, Barlier A, Dufour H, Chinot OL.

Clin Cancer Res. 2020 Feb 1;26(3):552-557. doi: 10.1158/1078-0432.CCR-19-2109. Epub 2020 Jan 22.


Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network.

Soussain C, Choquet S, Blonski M, Leclercq D, Houillier C, Rezai K, Bijou F, Houot R, Boyle E, Gressin R, Nicolas-Virelizier E, Barrie M, Moluçon-Chabrot C, Lelez ML, Clavert A, Coisy S, Leruez S, Touitou V, Cassoux N, Daniau M, Ertault de la Bretonnière M, El Yamani A, Ghesquières H, Hoang-Xuan K.

Eur J Cancer. 2019 Aug;117:121-130. doi: 10.1016/j.ejca.2019.05.024. Epub 2019 Jul 3.


Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.

Autran D, Barrie M, Matta M, Monserrat C, Campello C, Petrirena G, Boucard C, Padovani L, Loundou A, Appay R, Graillon T, Dufour H, Figarella-Branger D, Chinot O, Tabouret E.

Anticancer Res. 2019 Feb;39(2):1035-1041. doi: 10.21873/anticanres.13210.


Beyond observation: Protocols and capabilities of an Emergency Department Observation Unit.

Southerland LT, Simerlink SR, Vargas AJ, Krebs M, Nagaraj L, Miller KN, Adkins EJ, Barrie MG.

Am J Emerg Med. 2019 Oct;37(10):1864-1870. doi: 10.1016/j.ajem.2018.12.049. Epub 2018 Dec 27.


Evaluation of a community-based ART programme after tapering home visits in rural Sierra Leone: a 24-month retrospective study.

Kelly JD, Frankfurter R, Lurton G, Conteh S, Empson SF, Daboh F, Kargbo B, Giordano T, Mukherjee J, Barrie MB.

SAHARA J. 2018 Dec;15(1):138-145. doi: 10.1080/17290376.2018.1527244.


Coping strategies and quality of life: a longitudinal study of high-grade glioma patient-caregiver dyads.

Baumstarck K, Chinot O, Tabouret E, Farina P, Barrié M, Campello C, Petrirena G, Hamidou Z, Auquier P.

Health Qual Life Outcomes. 2018 Aug 2;16(1):157. doi: 10.1186/s12955-018-0983-y.


Nursing management of patients with faecal incontinence.

Barrie M.

Nurs Stand. 2018 May 2;33(2):69-74. doi: 10.7748/ns.2018.e11167. Epub 2018 Apr 20.


Food Insecurity as a Risk Factor for Outcomes Related to Ebola Virus Disease in Kono District, Sierra Leone: A Cross-Sectional Study.

Kelly JD, Richardson ET, Drasher M, Barrie MB, Karku S, Kamara M, Hann K, Dierberg K, Hubbard A, Lindan CP, Farmer PE, Rutherford GW, Weiser SD.

Am J Trop Med Hyg. 2018 May;98(5):1484-1488. doi: 10.4269/ajtmh.17-0820. Epub 2018 Mar 15.


Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).

Reyes-Botero G, Cartalat-Carel S, Chinot OL, Barrie M, Taillandier L, Beauchesne P, Catry-Thomas I, Barrière J, Guillamo JS, Fabbro M, Frappaz D, Benouaich-Amiel A, Le Rhun E, Campello C, Tennevet I, Ghiringhelli F, Tanguy ML, Mokhtari K, Honnorat J, Delattre JY.

Oncologist. 2018 May;23(5):524-e44. doi: 10.1634/theoncologist.2017-0689. Epub 2018 Feb 22.


Bringing the Flipped Classroom to Day 1: A Novel Didactic Curriculum for Emergency Medicine Intern Orientation.

Barrie MG, Amick C, Mitzman J, Way DP, King AM.

West J Emerg Med. 2018 Jan;19(1):145-147. doi: 10.5811/westjem.2017.11.35286. Epub 2017 Dec 18.


Replacing Lectures with Small Groups: The Impact of Flipping the Residency Conference Day.

King AM, Mayer C, Barrie M, Greenberger S, Way DP.

West J Emerg Med. 2018 Jan;19(1):11-17. doi: 10.5811/westjem.2017.10.35235. Epub 2017 Dec 18.


Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16.

Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Drasher M, Schlough GW, Dierberg K, Koedoyoma S, Lindan CP, Jones JH, Chamie G, Worden L, Greenhouse B, Weiser SD, Porco TC, Rutherford GW, Richardson ET.

J Infect Dis. 2018 Mar 28;217(8):1214-1221. doi: 10.1093/infdis/jiy004.


The symbolic violence of 'outbreak': A mixed methods, quasi-experimental impact evaluation of social protection on Ebola survivor wellbeing.

Richardson ET, Kelly JD, Sesay O, Drasher MD, Desai IK, Frankfurter R, Farmer PE, Barrie MB.

Soc Sci Med. 2017 Dec;195:77-82. doi: 10.1016/j.socscimed.2017.11.018. Epub 2017 Nov 11.


Epidemiology of clinical feline herpesvirus infection in zoo-housed cheetahs (Acinonyx jubatus).

Witte CL, Lamberski N, Rideout BA, Vaida F, Citino SB, Barrie MT, Haefele HJ, Junge RE, Murray S, Hungerford LL.

J Am Vet Med Assoc. 2017 Oct 15;251(8):946-956. doi: 10.2460/javma.251.8.946.


The predicament of patients with suspected Ebola - Authors' reply.

Richardson ET, Fallah MP, Kelly JD, Barrie MB.

Lancet Glob Health. 2017 Jul;5(7):e660-e661. doi: 10.1016/S2214-109X(17)30210-3. No abstract available.


Herbert Barrie.

Barrie M.

BMJ. 2017 May 8;357:j2187. doi: 10.1136/bmj.j2187. No abstract available.


Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan.

Farina P, Tabouret E, Lehmann P, Barrie M, Petrirena G, Campello C, Boucard C, Graillon T, Girard N, Chinot O.

J Neurooncol. 2017 May;132(3):433-437. doi: 10.1007/s11060-017-2385-0. Epub 2017 Mar 6.


The Ebola suspect's dilemma.

Richardson ET, Barrie MB, Nutt CT, Kelly JD, Frankfurter R, Fallah MP, Farmer PE.

Lancet Glob Health. 2017 Mar;5(3):e254-e256. doi: 10.1016/S2214-109X(17)30041-4. No abstract available.


Emergency Medicine Resident Orientation: How Training Programs Get Their Residents Started.

McGrath J, Barrie M, Way DP.

West J Emerg Med. 2017 Jan;18(1):97-104. doi: 10.5811/westjem.2016.10.31275. Epub 2016 Nov 15.


Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.

Richardson ET, Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Marsh RH, Koedoyoma S, Daboh F, Barron KP, Grady M, Tucker E, Dierberg KL, Rutherford GW, Barry M, Jones JH, Murray MB, Farmer PE.

PLoS Negl Trop Dis. 2016 Nov 15;10(11):e0005087. doi: 10.1371/journal.pntd.0005087. eCollection 2016 Nov.


Biosocial Approaches to the 2013-2016 Ebola Pandemic.

Richardson ET, Barrie MB, Kelly JD, Dibba Y, Koedoyoma S, Farmer PE.

Health Hum Rights. 2016 Jun;18(1):115-128.


Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone.

Cancedda C, Davis SM, Dierberg KL, Lascher J, Kelly JD, Barrie MB, Koroma AP, George P, Kamara AA, Marsh R, Sumbuya MS, Nutt CT, Scott KW, Thomas E, Bollbach K, Sesay A, Barrie A, Barrera E, Barron K, Welch J, Bhadelia N, Frankfurter RG, Dahl OM, Das S, Rollins RE, Eustis B, Schwartz A, Pertile P, Pavlopoulos I, Mayfield A, Marsh RH, Dibba Y, Kloepper D, Hall A, Huster K, Grady M, Spray K, Walton DA, Daboh F, Nally C, James S, Warren GS, Chang J, Drasher M, Lamin G, Bangura S, Miller AC, Michaelis AP, McBain R, Broadhurst MJ, Murray M, Richardson ET, Philip T, Gottlieb GL, Mukherjee JS, Farmer PE.

J Infect Dis. 2016 Oct 15;214(suppl 3):S153-S163. Epub 2016 Sep 28.


Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life.

Baumstarck K, Leroy T, Hamidou Z, Tabouret E, Farina P, Barrié M, Campello C, Petrirena G, Chinot O, Auquier P.

J Neurooncol. 2016 Aug;129(1):155-64. doi: 10.1007/s11060-016-2161-6. Epub 2016 Jun 14.


The Majority of the Pre-Antiretroviral Population Who Were Lost to Follow-Up Stopped Their Care in Freetown, Sierra Leone: A 12-Month Prospective Cohort Study Starting with HIV Diagnosis.

Kelly JD, Schlough GW, Conteh S, Barrie MB, Kargbo B, Giordano TP.

PLoS One. 2016 Feb 22;11(2):e0149584. doi: 10.1371/journal.pone.0149584. eCollection 2016.


Pathology in Practice. Cardiac hemangiosarcoma in a snake.

Shoemaker M, Barrie M, Holman H, Wolk KE, Stromberg PC, Aeffner F.

J Am Vet Med Assoc. 2016 Jan 15;248(2):153-5. doi: 10.2460/javma.248.2.153. No abstract available.


Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.

Omuro A, Chinot O, Taillandier L, Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S, Soubeyran P, Huchet A, Benouaich-Amiel A, Lebouvier-Sadot S, Gyan E, Touitou V, Barrié M, del Rio MS, Gonzalez-Aguilar A, Houillier C, Delgadillo D, Lacomblez L, Tanguy ML, Hoang-Xuan K.

Lancet Haematol. 2015 Jun;2(6):e251-9. doi: 10.1016/S2352-3026(15)00074-5. Epub 2015 Jun 3.


Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome.

Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D, Chinot O, Bruder N.

J Neurooncol. 2016 Mar;127(1):111-7. doi: 10.1007/s11060-015-2015-7. Epub 2015 Nov 25.


BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.

Tabouret E, Bequet C, Denicolaï E, Barrié M, Nanni I, Metellus P, Dufour H, Chinot O, Figarella-Branger D.

Eur J Surg Oncol. 2015 Dec;41(12):1685-90. doi: 10.1016/j.ejso.2015.09.012. Epub 2015 Sep 30.


MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma.

Tabouret E, Boudouresque F, Farina P, Barrié M, Bequet C, Sanson M, Chinot O.

Neuro Oncol. 2015 Aug;17(8):1174-6. doi: 10.1093/neuonc/nov094. No abstract available.


Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen.

Tabouret E, Reyes-Botero G, Dehais C, Daros M, Barrie M, Matta M, Petrirena G, Autran D, Duran A, Bequet C, Delattre JY, Chinot O.

Anticancer Res. 2015 May;35(5):2901-8.


Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.

Lassen U, Chinot OL, McBain C, Mau-Sørensen M, Larsen VA, Barrie M, Roth P, Krieter O, Wang K, Habben K, Tessier J, Lahr A, Weller M.

Neuro Oncol. 2015 Jul;17(7):1007-15. doi: 10.1093/neuonc/nov019. Epub 2015 Feb 9.


Primary neurolymphomatosis diagnosis and treatment: a retrospective study.

Lagarde S, Tabouret E, Matta M, Franques J, Attarian S, Pouget J, Maues De Paula A, Figarella-Branger D, Dory-Lautrec P, Chinot O, Barrié M.

J Neurol Sci. 2014 Jul 15;342(1-2):178-81. doi: 10.1016/j.jns.2014.04.030. Epub 2014 May 1.


Bing-Neel syndrome: a cerebral Richter syndrome?

Tabouret E, Coso D, Matta M, Barrié M, Bouabdallah R, Chinot O.

Neurol India. 2014 Mar-Apr;62(2):229-30. doi: 10.4103/0028-3886.132451. No abstract available.


Monteggia lesion in an Asian small-clawed otter (Aonyx cinerea).

Peters HJ, Hettlich BF, Barrie MT.

J Zoo Wildl Med. 2013 Dec;44(4):1063-7.


Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.

Tabouret E, Boudouresque F, Barrie M, Matta M, Boucard C, Loundou A, Carpentier A, Sanson M, Metellus P, Figarella-Branger D, Ouafik L, Chinot O.

Neuro Oncol. 2014 Mar;16(3):392-9. doi: 10.1093/neuonc/not226. Epub 2013 Dec 9.


Fatal Streptococcus anginosus-associated pneumonia in a captive Sumatran orangutan (Pongo abelii).

Ihms EA, Daniels JB, Koivisto CS, Barrie MT, Russell DS.

J Med Primatol. 2014 Feb;43(1):48-51. doi: 10.1111/jmp.12085. Epub 2013 Sep 30.


Development of a case definition for clinical feline herpesvirus infection in cheetahs (Acinonyx jubatus) housed in zoos.

Witte CL, Lamberski N, Rideout BA, Fields V, Teare CS, Barrie M, Haefele H, Junge R, Murray S, Hungerford LL.

J Zoo Wildl Med. 2013 Sep;44(3):634-44.


Multiple self-report measures of antiretroviral adherence correlated in Sierra Leone, but did they agree?

Kelly JD, Hubenthal EA, Lurton G, Empson SF, Barrie MB, Kargbo B, Wagner GJ, Giordano TP.

Int J STD AIDS. 2013 Dec;24(12):931-7. doi: 10.1177/0956462413487327. Epub 2013 Jul 15.


Integrated medical school ultrasound: development of an ultrasound vertical curriculum.

Bahner DP, Adkins EJ, Hughes D, Barrie M, Boulger CT, Royall NA.

Crit Ultrasound J. 2013 Jul 2;5(1):6. doi: 10.1186/2036-7902-5-6.


Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen.

Tabouret E, Barrie M, Thiebaut A, Matta M, Boucard C, Autran D, Loundou A, Chinot O.

J Neurooncol. 2013 Sep;114(2):191-8. doi: 10.1007/s11060-013-1170-y. Epub 2013 Jun 12.


Housing equity for health equity: a rights-based approach to the control of Lassa fever in post-war Sierra Leone.

Kelly JD, Barrie MB, Ross RA, Temple BA, Moses LM, Bausch DG.

BMC Int Health Hum Rights. 2013 Jan 2;13:2. doi: 10.1186/1472-698X-13-2.


Association of carcinoid tumor and low grade glioma.

Tabouret E, Barrié M, Vicier C, Gonçalves A, Chinot O, Viens P, Madroszyk A.

World J Surg Oncol. 2012 Nov 8;10:236. doi: 10.1186/1477-7819-10-236.


Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.

Philippon M, Morange I, Barrie M, Barlier A, Taieb D, Dufour H, Conte-Devolx B, Brue T, Castinetti F.

Ann Endocrinol (Paris). 2012 Jun;73(3):225-9. doi: 10.1016/j.ando.2012.03.001. Epub 2012 Apr 20.


FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.

Colavolpe C, Chinot O, Metellus P, Mancini J, Barrie M, Bequet-Boucard C, Tabouret E, Mundler O, Figarella-Branger D, Guedj E.

Neuro Oncol. 2012 May;14(5):649-57. doi: 10.1093/neuonc/nos012. Epub 2012 Feb 29.


Genetic characterization of peste des petits ruminants virus, Sierra Leone.

Munir M, Zohari S, Suluku R, Leblanc N, Kanu S, Sankoh FA, Berg M, Barrie ML, Ståhl K.

Emerg Infect Dis. 2012 Jan;18(1):193-5. doi: 10.3201/eid1801.111304. No abstract available.


Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid Treatment.

Barrie M, McKnight L, Solanki P.

Case Rep Crit Care. 2012;2012:262815. doi: 10.1155/2012/262815. Epub 2012 Dec 4.


Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.

Colavolpe C, Metellus P, Mancini J, Barrie M, Béquet-Boucard C, Figarella-Branger D, Mundler O, Chinot O, Guedj E.

J Neurooncol. 2012 May;107(3):527-35. doi: 10.1007/s11060-011-0771-6. Epub 2011 Dec 15.


Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.

Gállego Pérez-Larraya J, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo JS, Campello C, Monjour A, Cartalat-Carel S, Barrie M, Huchet A, Beauchesne P, Matta M, Mokhtari K, Tanguy ML, Honnorat J, Delattre JY.

J Clin Oncol. 2011 Aug 1;29(22):3050-5. doi: 10.1200/JCO.2011.34.8086. Epub 2011 Jun 27.


IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients.

Metellus P, Colin C, Taieb D, Guedj E, Nanni-Metellus I, de Paula AM, Colavolpe C, Fuentes S, Dufour H, Barrie M, Chinot O, Ouafik L, Figarella-Branger D.

J Neurooncol. 2011 Dec;105(3):591-600. doi: 10.1007/s11060-011-0625-2. Epub 2011 Jun 5.


Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.

Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D.

Ann Surg Oncol. 2011 Oct;18(10):2937-45. doi: 10.1245/s10434-011-1703-6. Epub 2011 Apr 9.


Supplemental Content

Loading ...
Support Center